Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| AMGN | NASDAQ | Amgen Inc. | $403.42 | -1.08% | 1.7M | $217.73B |
| GILD | NASDAQ | Gilead Sciences, Inc. | $130.86 | -0.68% | 8.2M | $162.47B |
| ISRG | NASDAQ | Intuitive Surgical, Inc. | $375.20 | +1.88% | 3.3M | $132.55B |
| VRTX | NASDAQ | Vertex Pharmaceuticals Incorporated | $483.72 | -0.23% | 622K | $122.77B |
| SNY | NASDAQ | Sanofi | $42.89 | +0.26% | 4.1M | $102.99B |
| REGN | NASDAQ | Regeneron Pharmaceuticals, Inc. | $768.58 | +1.04% | 505K | $79.18B |
| ARGX | NASDAQ | argenx SE | $864.38 | +2.35% | 358K | $53.98B |
| IDXX | NASDAQ | IDEXX Laboratories, Inc. | $584.78 | -0.56% | 846K | $46.13B |
| RVMD | NASDAQ | Revolution Medicines, Inc. | $197.30 | +1.98% | 1.7M | $41.95B |
| RVMDW | NASDAQ | Revolution Medicines, Inc. Warrant | $10.25 | +2.30% | 119K | $41.8B |
| NTRA | NASDAQ | Natera, Inc. | $274.62 | -0.21% | 1.1M | $39.33B |
| ONC | NASDAQ | BeOne Medicines AG | $329.80 | +0.69% | 263K | $35.24B |
| GEHC | NASDAQ | GE HealthCare Technologies Inc. | $70.24 | -0.03% | 2.8M | $31.73B |
| DXCM | NASDAQ | DexCom, Inc. | $82.66 | -4.92% | 5.5M | $31.19B |
| MDLN | NASDAQ | Medline Inc. | $36.67 | -12.79% | 24.8M | $31B |
| BIIB | NASDAQ | Biogen Inc. | $205.97 | -1.19% | 796K | $30.53B |
| ILMN | NASDAQ | Illumina, Inc. | $199.87 | -1.55% | 2.3M | $30.24B |
| ALNY | NASDAQ | Alnylam Pharmaceuticals, Inc. | $216.68 | -5.26% | 1.2M | $28.99B |
| ROIV | NASDAQ | Roivant Sciences Ltd. | $34.60 | +0.03% | 5.8M | $25B |
| RPRX | NASDAQ | Royalty Pharma plc | $57.75 | +0.47% | 3.5M | $24.84B |
| INCY | NASDAQ | Incyte Corporation | $116.64 | -2.64% | 1.3M | $23.64B |
| BNTX | NASDAQ | BioNTech SE | $92.32 | +1.06% | 1.7M | $23.16B |
| MRNA | NASDAQ | Moderna, Inc. | $56.26 | -1.29% | 5.1M | $22.32B |
| UTHR | NASDAQ | United Therapeutics Corporation | $519.01 | +0.06% | 737K | $22.03B |
| INSM | NASDAQ | Insmed Incorporated | $99.02 | +0.27% | 4.9M | $21.46B |
| GH | NASDAQ | Guardant Health, Inc. | $157.58 | -3.43% | 1.5M | $21.15B |
| VTRS | NASDAQ | Viatris Inc. | $17.65 | -0.28% | 10.4M | $20.55B |
| GMAB | NASDAQ | Genmab A/S | $29.26 | +0.83% | 1.4M | $17.96B |
| JAZZ | NASDAQ | Jazz Pharmaceuticals plc | $261.57 | -0.02% | 687K | $16.43B |
| MEDP | NASDAQ | Medpace Holdings, Inc. | $587.75 | +2.20% | 241K | $16.41B |
| NBIX | NASDAQ | Neurocrine Biosciences, Inc. | $161.50 | -2.75% | 1.3M | $16.24B |
| BBIO | NASDAQ | BridgeBio Pharma, Inc. | $82.33 | +0.42% | 493K | $16.13B |
| ASND | NASDAQ | Ascendis Pharma A/S | $249.85 | +2.31% | 471K | $15.52B |
| COO | NASDAQ | The Cooper Companies, Inc. | $74.30 | -0.52% | 641K | $14.49B |
| EXEL | NASDAQ | Exelixis, Inc. | $52.61 | -7.21% | 3.1M | $13.22B |
| ICLR | NASDAQ | ICON Public Limited Company | $163.51 | +4.25% | 601K | $12.52B |
| BTSG | NASDAQ | BrightSpring Health Services, Inc. Common Stock | $62.74 | -0.05% | 3.2M | $12.37B |
| ALGN | NASDAQ | Align Technology, Inc. | $171.72 | -1.78% | 247K | $12.3B |
| ARWR | NASDAQ | Arrowhead Pharmaceuticals, Inc. | $87.53 | -2.30% | 1.7M | $12.24B |
| CORT | NASDAQ | Corcept Therapeutics Incorporated | $110.69 | +0.81% | 847K | $11.97B |
| MDGL | NASDAQ | Madrigal Pharmaceuticals, Inc. | $514.12 | +1.29% | 327K | $11.88B |
| BTSGU | NASDAQ | BrightSpring Health Services, Inc. Tangible Equity Unit | $200.84 | -3.30% | 1K | $11.8B |
| BMRN | NASDAQ | BioMarin Pharmaceutical Inc. | $59.75 | -0.27% | 1.1M | $11.55B |
| TECH | NASDAQ | Bio-Techne Corporation | $71.98 | -0.03% | 860K | $11.27B |
| AXSM | NASDAQ | Axsome Therapeutics, Inc. | $211.97 | -0.09% | 579K | $10.95B |
| SMMT | NASDAQ | Summit Therapeutics Inc. | $13.50 | -0.22% | 723K | $10.77B |
| ENSG | NASDAQ | The Ensign Group, Inc. | $181.66 | +1.68% | 306K | $10.59B |
| HSIC | NASDAQ | Henry Schein, Inc. | $89.59 | +0.54% | 1.6M | $10.21B |
| HALO | NASDAQ | Halozyme Therapeutics, Inc. | $83.59 | +0.43% | 1.3M | $9.91B |
| CYTK | NASDAQ | Cytokinetics, Incorporated | $78.85 | +0.31% | 1.6M | $9.81B |